Cubist Systematic Strategies LLC Buys 11,051 Shares of Cardinal Health, Inc. (CAH)
Cubist Systematic Strategies LLC boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 70.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 26,654 shares of the company’s stock after buying an additional 11,051 shares during the period. Cubist Systematic Strategies LLC’s holdings in Cardinal Health were worth $1,784,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the stock. Bronfman E.L. Rothschild L.P. grew its position in Cardinal Health by 31.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after acquiring an additional 382 shares during the last quarter. Advisory Services Network LLC grew its position in Cardinal Health by 18.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock valued at $136,000 after acquiring an additional 270 shares during the last quarter. Dupont Capital Management Corp bought a new position in Cardinal Health in the 2nd quarter valued at $164,000. First Personal Financial Services grew its position in Cardinal Health by 127.5% in the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after acquiring an additional 1,238 shares during the last quarter. Finally, Sun Life Financial INC grew its position in Cardinal Health by 16,228.6% in the 2nd quarter. Sun Life Financial INC now owns 2,286 shares of the company’s stock valued at $178,000 after acquiring an additional 2,272 shares during the last quarter. Institutional investors own 88.47% of the company’s stock.
CAH has been the topic of several research analyst reports. Jefferies Group set a $77.00 price objective on Cardinal Health and gave the company a “hold” rating in a research report on Tuesday, August 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardinal Health in a research report on Sunday, September 10th. Robert W. Baird reaffirmed a “hold” rating and issued a $73.00 price objective on shares of Cardinal Health in a research report on Sunday, September 17th. Royal Bank of Canada initiated coverage on Cardinal Health in a research report on Tuesday, September 19th. They issued a “sector perform” rating and a $72.00 price objective on the stock. Finally, Cowen raised Cardinal Health to a “buy” rating and set a $74.00 price objective on the stock in a research report on Tuesday, October 10th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $73.91.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The business had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $33.48 billion. During the same quarter in the prior year, the company earned $1.24 EPS. The business’s revenue was up 1.9% compared to the same quarter last year. research analysts forecast that Cardinal Health, Inc. will post 4.96 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be given a dividend of $0.4624 per share. This represents a $1.85 dividend on an annualized basis and a yield of 2.93%. The ex-dividend date is Friday, December 29th. Cardinal Health’s payout ratio is currently 53.78%.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.